Robert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionai
Drugs Like Ozempic Could Lower Cancer Risks, Study Suggests
The research adds to research suggesting benefits for a growing number of health conditions and bolster the public health case for insurers to cover the treatments.
Samsung Soars To Three-Year High As AI Boom Bolsters Chip Business
The South Korean tech giant said it expects to rake in second quarter profits more than 15 times the size than it did the same time last year.
U.K. Elections Are Underway: What To Know As Conservatives Head For Crushing Defeat
Labour Party leader Sir Keir Starmer is expected to succeed Rishi Sunak as the U.K.’s next prime minister.
China Thrashes U.S. In Global AI Patent Race—Here’s Why That Doesn’t Mean It’s Winning The AI War
China has filed more than six times as many patents for generative AI inventions than the U.S. over the last decade but patent filings offer only a “partial view” on the global race to control the critical technology, a legal expert told Forbes.
SoftBank Shares Hit Record High Amid Push Into AI And Computer Chips
The climb indicates confidence in the investment titan’s new pivot towards AI and semiconductor chips after CEO Masayoshi Son last month described past commitments as a mere “warm up” for its push into artificial intelligence.